Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 34 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 9102744

    Conjugated anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  2. US 9101670

    Conjugates of an anti-TNF-α antibody

    Nektar Therapeutics · Granted Aug 11, 2015 · Expires Aug 6, 2035

    granted

  3. US 9095539

    Anti-adhesin based passive immunoprophylactic

    United States of America as represented by the Secretary of the Air Force · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  4. US 9095608

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  5. US 9095558

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  6. US 9084762

    T-cell immunogens derived from anti-viral proteins and methods of using same

    The Regents of the University of California · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  7. US 9072767

    Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses

    UNITED PHARMACEUTICALS · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  8. US 9073884

    Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them

    The Regents of the University of California · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted

  9. US 9044457

    Anti-DR4 agonist antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  10. US 9017670

    Anti-Tie2 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  11. US 9018356

    Anti-ANGPTL3 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted

  12. US 9012647

    Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  13. US 9006399

    Anti-OX40 antibodies and methods of using the same

    The Board of Regents of the University of Texas System · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  14. US 8987305

    2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

    APTOSE BIOSCIENCES INC. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  15. US 8980268

    Methods for treating cancer by administering an anti-Ang-2 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  16. US 8969372

    Aryl imidazoles and their use as anti-cancer agents

    Aptose Boisciences Inc. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  17. US 8945559

    Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  18. US 8940298

    High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection

    The Regents of the University of California · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted

  19. US 8940871

    Engineered anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting

    The Regents of the University of California · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted

  20. US 8940301

    Breast tumor treatment with anti-CXCR1 compositions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted

  21. US 2015017178

    Anti-CD26 Antibodies and Uses Thereof

    ADIENNE S R L S U [IT] · Granted Jan 15, 2015 · Expires Jan 10, 2035

    granted

  22. US 8926969

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  23. US 8912185

    Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  24. US 8901279

    Humanized antibodies with anti-tumor activity

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.